NewsMarkets

Health

Trump Administration Plans Funding for Ibogaine PTSD Research

The Trump administration will allocate up to $4.9 million to support research into the psychedelic drug ibogaine as a potential treatment for PTSD.

2 publishers · 2 articles · first seen 12 Nov 2026 · updated 2d ago

Headline and summary written by an AI model from the linked articles; not reviewed by a person. How this was made

This story has stopped developing; this page is its permanent record. More from that day

The story so far

2 publishers have covered this in 2 articles since 12 Nov 2026. MedPageToday.com - medical news for physicians published first, on 12 November at 22:00 UTC; STAT followed 17h 25m later. The most recent article, from STAT, appeared on 13 November at 15:25 UTC.

Outlets reporting it: MedPageToday.com - medical news for physicians, STAT.

No prediction market is linked to this story at the moment. We match each story to Polymarket and Kalshi markets by what they ask, and show one only when it is close enough to be useful; if a market on this topic opens, it will appear here. Meanwhile, browse every market we track or see how stories and markets are matched.

Sources

Every article we clustered into this story. Headlines link to the publisher.

  1. STAT+: HHS plans funding for research into ibogaine for PTSD STAT
  2. Trump Officials Will Fund New Research on Controversial Psychedelic Drug Ibogaine MedPageToday.com - medical news for physicians

In this story

Embed this story

Paste this into any web page to show the live odds, with a link back here.